Back to search
FDAFDA · Food and drugs·Recall number D-0045-2027

Amlodipine and Olmesartan Medoxomil Tablets, 10mg/40mg, 30 Tablets, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-502-30.

Published October 28, 2026 · Recall initiated: October 6, 2026

Summary

FDA records drug Class II recall D-0045-2027, published October 28, 2026 and initiated October 6, 2026. Recalling firm: Ascend Laboratories, LLC; Status: Ongoing; Reported quantity: 11,424 bottles.; Lot: Lot # 25120696, Exp Date: December 31, 2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Out of specification due to dissolution.

What to do

Voluntary: Firm initiated · Letter

Get an email if AMLODIPINE AND OLMESARTAN MEDOXOMIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
AMLODIPINE AND OLMESARTAN MEDOXOMIL
Manufacturer
Ascend Laboratories, LLC
Distributor
Nationwide within the United States
Lot
Lot # 25120696, Exp Date: December 31, 2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amlodipine and Olmesartan Medoxomil Tablets, 10mg/40mg, 30 Tablets, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-502-30. recalled?

Yes. FDA published recall D-0045-2027 on October 28, 2026. Reported hazard: Out of specification due to dissolution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: AMLODIPINE AND OLMESARTAN MEDOXOMIL.